Fulminant ulcerative colitis complicated with toxic megacolon

Colitis ulcerativa fulminante complicada con megacolon tóxico

Main Article Content

Gelca Patricia Danies Diaz
María del Socorro Alzamora Acosta
Gustavo Adolfo Domínguez Ramírez
Paola María Blanco Pertúz
Julián David Meléndez Albarracín

Abstract

We present a case of acute abdomen secondary to perforated toxic megacolon in a patient with new-onset ulcerative colitis (UC) that required multiple surgical interventions and prolonged intensive care unit stay. Toxic megacolon is a rare but potentially fatal complication of UC, being even rarer in new-onset UC in a patient with no history and only one risk factor identified, considering this an opportunity to share its study and approach. The diagnosis of toxic megacolon is based on the criteria proposed by Jalan. Although the initial treatment is medical therapy with intravenous corticosteroids, surgical management is necessary for a significant majority of patients.

Keywords:

Downloads

Download data is not yet available.

Article Details

References

Lynch WD, Hsu R. Colitis ulcerosa. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 [citado 2020 Jun 25]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK459282/

Hernández-Rocha C, Ibáñez P, Molina ME, Klaassen J, Valenzuela A, Candia R, et al. Diagnóstico y manejo de colitis ulcerosa grave: Una mirada actualizada. Rev Med Chile. 2017;145(1), 75-84.

Pérez-Quintero R, García-del Pino B, González-Benjumea M P, Reyes-Moreno M, Perea-Sánchez MJ, de Arboleya RMG. et al. Megacolon tóxico como debut en colitis ulcerosa. Cirugía Andaluza. 2019;30(1):146-49.

Nero J, Targownik LE. Toxic Megacolon. Encyclopedia of Gastroenterology. Second Edition. United Kingdom: Academic Press. Elsevier; 2018.

Desai J, Elnaggar M, Hanfy AA, Doshi R. Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions. Clin Exp Gastroenterol. 2020;13:203-210. doi: 10.2147/CEG.S200760

Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, et al. A comprehensive review and update on ulcerative colitis. Disease-a-Month. 2019;65(12):100851 doi.org/10.1016/j.disamonth.2019.02.004

Kamalian A, Asl MS, Dolatshahi M, Afshari K, Shamshiri S, Roudsari NM, et al. Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways. World J Gastroenterol. 2020;26(24):3365-3400. doi: 10.3748/wjg.v26.i24.3365

Cao W, Fiocchi C, Pricolo VE. Production of IL-1β, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis. Am J Physiol Cell Physiol. 2005;289(6):C1408-16. doi:10.1152/ajpcell.00073.2005

Barreiro-de Acosta, M. Colitis Ulcerosa. Medicine. 2016;12(5):227-41. doi: 10.1016/j.med.2016.02.019

Ghormade PS, Sahu BK, Sharma B. Fatal Toxic Megacolon during Exacerbation of Ulcerative Colitis in Puerperium. Journal of Case Reports. 2020;10(2):127-131. doi:10.17659/01.2020.0034

Moulin, V., Dellon, P., Laurent, O., Aubry, S., Lubrano, J., Delabrousse, E. Toxic megacolon in patients with severe acute colitis: computed tomographic features. Clin Imaging. 2011;35(6):431-436. doi: 10.1016/j.clinimag.2011.01.012.

Sobrado CW, Sobrado LF. Management of acute severe ulcerative colitis: a clinical update. ABCD, arq. bras. cir. dig (São Paulo). 2016;29(3):201-205. doi: 10.1590/0102-6720201600030017

Triantafillidis JK, Vagianos C, Papalois AE. The role of enteral nutrition in patients with inflammatory bowel disease: current aspects. Biomed Res Int. 2015;2015:197167. doi: 10.1155/2015/197167

Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1-s106. doi: 10.1136/gutjnl-2019-318484

Singh S, Allegretti JR, Siddique SM, Terdiman JP. AGA technical review on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020;158(5):1465–1496.e17. doi: 10.1053/j.gastro.2020.01.007

Hindryckx PIETER, Novak G, Vande Casteele N, Laukens D, Parker C, Shackelton LM, Sandborn WJ. Dose optimisation of infliximab for acute severe ulcerative colitis. Alimentary pharmacology & therapeutics. Aliment Pharmacol Ther. 2017 Mar;45(5):617-630. doi: 10.1111/apt.13913

Alshammari RM, Alhussain SM, Al Fateel ZA, Al Wtayyan HA, Muammar MFB, Alhussain AM, et al. Evaluation of Recent Surgical Updates in the Management of Ulcerative Colitis: A Simple Literature Review. Arch Pharma Pract. 2019;10(3):25-8.

Gallo G, Kotze PG, Spinelli A. Surgery in ulcerative colitis: When? How?. Best Pract Res Clin Gastroenterol. 2018;32-33:71-78. doi: 10.1016/j.bpg.2018.05.017.

Citado por